US Broker Ratings

Baxter International Inc. (BAX) Stock Analysis: Exploring an 18.20% Potential Upside Amidst Healthcare Growth

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, operates in the medical instruments and supplies industry with a market capitalization of $9.66 billion. With a rich..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unlocking a 62.65% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a stalwart in the biotechnology sector, continues to capture the attention of investors with its promising pipeline and strong market presence in treatment for rare..

United Therapeutics Corporation (UTHR) Stock Analysis: A Robust Healthcare Play with a 9.47% Upside

United Therapeutics Corporation (NASDAQ: UTHR) presents a compelling opportunity for investors seeking exposure to the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. With a market..

Edwards Lifesciences Corporation (EW) Stock Analysis: A High-Stakes Bet in Medical Devices with 18.94% Upside

Investors with an eye on the healthcare sector may find Edwards Lifesciences Corporation (NYSE: EW) an intriguing opportunity, thanks to its innovative edge in the medical devices industry and a..

Universal Health Services, Inc. (UHS) Stock Analysis: A Potential 35.60% Upside in Healthcare Investment

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, offers an intriguing investment opportunity with a potential upside of 35.60%. With a market capitalization of $11.14..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A 45% Potential Upside Amidst Robust Revenue Growth

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading player in the biotechnology sector, has captured investor attention with its cutting-edge therapeutics based on ribonucleic acid interference (RNAi). With a market capitalization..

Natera, Inc. (NTRA) Stock Analysis: A 23.78% Potential Upside Amid Robust Revenue Growth

Natera, Inc. (NASDAQ: NTRA) is capturing the attention of investors with its strong footing in the healthcare sector, specifically within the diagnostics and research industry. As a leader in molecular..

GE HealthCare Technologies Inc. (GEHC): Investor Outlook on a Medical Device Giant with a 21.53% Potential Upside

For investors seeking opportunities in the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents a compelling prospect. The company, which operates in the medical devices industry, has established itself..

STERIS plc (STE) Stock Analysis: A 23.69% Potential Upside Amidst Strong Revenue Growth

As investors navigate the dynamic landscape of the healthcare sector, STERIS plc (NYSE: STE) emerges as a compelling prospect. With a market capitalization of $22.16 billion, STERIS stands as a..

Zoetis Inc. (ZTS) Stock Analysis: Promising 22.81% Upside with Strong Analyst Confidence

For investors seeking opportunities in the healthcare sector, Zoetis Inc. (NYSE: ZTS) presents a compelling case. As a leader in the animal health industry, Zoetis is well-positioned to benefit from..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 31% Upside Potential Amid Robust Revenue Growth

IQVIA Holdings, Inc. (NYSE: IQV), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents an intriguing opportunity for investors. Based in Durham, North Carolina,..

Stryker Corporation (SYK) Stock Analysis: Exploring a Potential 22% Upside in the Medical Device Powerhouse

Stryker Corporation (NYSE: SYK), a titan in the healthcare sector, is gaining attention from investors with its robust market cap of $131.49 billion and a promising potential upside of 22.08%...

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Unlocking Growth Potential with an 8.62% Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the medical devices industry, is garnering attention with its robust growth prospects and a notable potential upside of 8.62%. With..

Amgen Inc. (AMGN) Investor Outlook: Examining the Healthcare Giant’s 106% ROE and Analyst Ratings

Amgen Inc. (NASDAQ: AMGN), a prominent player in the healthcare sector, continues to capture investor interest with its robust portfolio of therapeutics and impressive financial metrics. The company, headquartered in..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 24.94% Potential Upside in the Healthcare Sector

CVS Health Corporation (NYSE: CVS) remains a formidable player in the healthcare sector, with a market capitalization of $99.07 billion. The company, known for its comprehensive health solutions, operates through..

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A Healthcare Giant with 24% Upside Potential

Investors seeking opportunities in the healthcare sector should take a closer look at IDEXX Laboratories, Inc. (NASDAQ: IDXX). This diagnostics and research powerhouse boasts a market capitalization of $46.92 billion,..

Waters Corporation (WAT) Stock Analysis: Unpacking a 17.61% Potential Upside in the Diagnostics & Research Sector

Investors looking for opportunities in the healthcare sector might find Waters Corporation (NYSE: WAT) an intriguing prospect, given its strategic positioning in the diagnostics and research industry. With a market..

ResMed Inc. (RMD) Investor Outlook: Unveiling a 28% Potential Upside in the Healthcare Sector

For investors keen on the healthcare sector, ResMed Inc. (NYSE: RMD) is a noteworthy contender, offering significant growth potential. With a market capitalization of $33.3 billion, ResMed stands as a..

AstraZeneca PLC (AZN) Stock Analysis: Eyeing Modest Upside Amid Strong Buy Ratings

AstraZeneca PLC (NASDAQ: AZN), a titan in the healthcare sector and a prominent player among general drug manufacturers, continues to garner significant investor interest. With a market capitalization of $317.5..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds